The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
with regard to carboxyl pyrol we actually know that um this molecule is creating autoimmunity in some people and so so this breakdown product um called Rock's ethylpyrol then can cause um sap we've shorten that to sap related antibodies and so those antibodies then can cross react with antigens in the retina and this may be part of macro degeneration
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.